Ramsay M, Kaczmarski E, Rush M, Mallard R, Farrington P, White J
Immunisation Division PHLS Communicable Disease Surveillance Centre, London.
Commun Dis Rep CDR Rev. 1997 Apr 4;7(4):R49-54.
We have reviewed data on meningococcal disease routinely collected in England and Wales from 1989 to 1995 to illustrate and explain changing patterns and guide future surveillance. Statutory notifications of meningococcal meningitis and septicaemia, laboratory confirmed infections, and death registrations coded as meningococcal disease were analysed in terms of their numbers, the age of cases, season of the report, and (if available) site of isolation, serogroup, and serotype. Case fatality rates were estimated for clinically diagnosed and culture confirmed cases. The number of cases notified each year, in particular those notified as septicaemia, rose significantly over the period (p < 0.0001) but there was no net change in the number of culture confirmed cases. Case fatality rates estimated from routine data fell, most markedly for cases notified as septicaemia, but the true case fatality rate of culture confirmed cases did not change between 1993 and 1995. These data suggest that reporting practice changed between 1989 and 1995 and that the ascertainment of clinically diagnosed disease improved, particularly for meningococcal septicaemia. Late in 1995, reports from all data sources increased and the age distribution of both notified and laboratory confirmed cases changed. These changes were accompanied by an increase in the proportion of infections due to Neisseria meningitidis of serogroup C and a significant increase in serotype C2a infections (p < 0.0001). Continuing efforts to reconcile data from several sources will be needed to ensure that routine data can be interpreted accurately to provide evidence for the development of future vaccination policy and to monitor vaccination programmes. In addition, the role of non-culture diagnosis will be crucial in enhancing surveillance based on clinical diagnoses.
我们回顾了1989年至1995年在英格兰和威尔士常规收集的关于脑膜炎球菌病的数据,以阐明和解释变化模式并指导未来的监测工作。对脑膜炎球菌性脑膜炎和败血症的法定通报、实验室确诊感染以及编码为脑膜炎球菌病的死亡登记信息,从病例数量、病例年龄、报告季节以及(若可获取)分离部位、血清群和血清型等方面进行了分析。对临床诊断病例和培养确诊病例的病死率进行了估算。在此期间,每年通报的病例数量,尤其是通报为败血症的病例数量显著上升(p < 0.0001),但培养确诊病例的数量没有净变化。根据常规数据估算的病死率下降,以通报为败血症的病例下降最为明显,但1993年至1995年期间培养确诊病例的实际病死率没有变化。这些数据表明,1989年至1995年期间报告做法发生了变化,临床诊断疾病的确诊率有所提高,尤其是脑膜炎球菌败血症。1995年末,所有数据来源的报告均增加,通报病例和实验室确诊病例的年龄分布也发生了变化。这些变化伴随着C群脑膜炎奈瑟菌引起的感染比例增加以及C2a血清型感染显著增加(p < 0.0001)。需要持续努力整合来自多个来源的数据,以确保能够准确解读常规数据,为制定未来疫苗接种政策提供证据并监测疫苗接种计划。此外,非培养诊断在加强基于临床诊断的监测方面将至关重要。